Anthrax vaccination by targeting spore germination
Anthrax vaccination by targeting spore germination
批准号:
6717426
负责人:
CHUN-MING HUANG
金额:
$28.91万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-30 至 2006-08-31
关键词:
Bacillus anthracisanthraxanthrax toxinanthrax vaccinesbacterial proteinsbiotechnologybioterrorism /chemical warfareinhibitor /antagonistlaboratory mousemembrane proteinsmetalloendopeptidasesmolecular cloningnucleic acid sequencereproductionsecretory proteinsporestopical drug applicationtransfection /expression vectorvaccine developmentvaccine evaluationvector vaccine
中文摘要
描述(由申请方提供):在炭疽芽孢杆菌的生命周期中,萌发是一个上游事件。萌发孢子可能被认为是其生命周期中最薄弱的环节,因为停止它们的功能将阻止疾病的进一步发展。因此,开发针对炭疽芽孢杆菌在萌发阶段表达的特异性蛋白的疫苗可能是阻止炭疽生长的有效策略。 阻断萌芽阶段将防止下游事件,包括炭疽三种天然毒素PA、LF和EF的产生,以及生物恐怖分子可能插入炭疽的任何其他外来毒素。
我们最近的特点是22发芽相关的蛋白质炭疽芽孢杆菌通过使用蛋白质组学技术。传统的蛋白质组学主要使用2D电泳和质谱法研究蛋白质。我们已经确定这些萌发蛋白质从孢子休眠到萌发的差异表达。已鉴定出11种蛋白质。它们包括一种分泌蛋白(免疫抑制剂A)、四种潜在的膜相关蛋白(骆驼溶素、丙氨酸消旋酶、Larabinose转运蛋白和L型钙通道)、两种分子伴侣(HSP 60和cpn 60)、两种能量相关蛋白(ATP合成酶和3-磷酸甘油醛脱氢酶)和一种新的炭疽特异性蛋白。免疫抑制剂A和骆驼溶素是炭疽杆菌中的毒力金属蛋白酶,未见报道。
博士Tang是本研究的共同主要研究者,他已经建立了一种基于载体疫苗的非侵入性疫苗接种系统。该系统将用于本研究开发炭疽疫苗,专门针对两种与发芽相关的蛋白质:免疫抑制剂A和骆驼溶素。我们还将比较我们实验室构建的PA和LF靶向疫苗。同时,将在体外和体内评价免疫抑制剂A和骆驼溶素衍生的疫苗,以确定其阻断孢子萌发和对巨噬细胞的细胞毒性的效力。
这项前所未有的研究将引发炭疽杆菌表达的免疫抑制剂A和骆驼溶素的病理机制和疫苗接种能力。
英文摘要
DESCRIPTION (provided by applicant): Germination occurs as an upstream event during the life cycle of Bacillus anthracis. Germinating spores may be considered the weakest link during its life cycle because stopping their function would prevent further development of the disease. Therefore, the development of vaccines against specific proteins expressed during the germination stage of Bacillus anthracis may be an effective strategy to halt the growth of anthrax. Blocking the germination stage would prevent downstream events including the production of anthrax's three natural toxins, PA, LF, and EF, as well as any other foreign toxins that bioterrorists may insert into anthrax.
We have recently characterized twenty-two germination-associated proteins from Bacillus anthracis by using proteomic techniques. Conventional proteomics studies proteins primarily using 2D electrophoresis and mass spectrometry. We have determined these germination proteins are differentially expressed from spore dormancy to germination. Eleven identified proteins have been identified. They include one secreted protein (Immune inhibitor A), four potential membrane-associated proteins (Camelysin, Alanine racemase, Larabinose transporter, and L-type calcium channel), two molecular chaperones (HSP60 and cpn60), two energy-related proteins (ATP synthase and Glyceraldehyde 3-phosphate dehydrogenase) and one novel anthrax specific protein. Immune inhibitor A and camelysin are virulent metalloproteinases and have been unreported in Bacillus anthracis.
Dr. Tang, a Co-PI in this study, has well-established a noninvasive vaccination system based on vector based vaccines applied to the skin. That system will be used in this study to develop anthrax vaccines that will specifically target two of the germination-associated proteins: immune inhibitor A and camelysin. We will also compare current PA and LF targeted vaccines that have been constructed in our laboratory. In parallel, vaccines derived from immune inhibitor A and camelysin will be evaluated in vitro and in vivo to determine their efficacies in blocking spore germination and cytotoxicity to macrophage cells.
This unprecedented study will elicit the pathological mechanisms and vaccination capabilities of immune inhibitor A and camelysin expressed in Bacillus anthracis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Skin Microbiome Editing with Fermentation Initiator
-
批准号:9407254
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2017
-
负责人:CHUN-MING HUANG
-
依托单位:
Deficiency of Short-Chain Fatty Acids in Acne Vulgaris
-
批准号:9316161
-
项目类别:
-
资助金额:$20.46万
-
财政年份:2017
-
负责人:CHUN-MING HUANG
-
依托单位:
Bacterial fermentation in skin microbiome as probiotics (Bfismp) against S. aureu
-
批准号:8452574
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2013
-
负责人:CHUN-MING HUANG
-
依托单位:
Indigenous Free Fatty Oleic acid Against MRSA Skin Infection
-
批准号:8081826
-
项目类别:
-
资助金额:$20.29万
-
财政年份:2010
-
负责人:CHUN-MING HUANG
-
依托单位:
Indigenous Free Fatty Oleic acid Against MRSA Skin Infection
-
批准号:7991210
-
项目类别:
-
资助金额:$25.72万
-
财政年份:2010
-
负责人:CHUN-MING HUANG
-
依托单位:
Acne Vaccines Targeting a Surface Sialidase and a Secreted CAMP Factor Toxin
-
批准号:7482001
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2008
-
负责人:CHUN-MING HUANG
-
依托单位:
Immunological Secretomes of the Early Anthrax Infection
-
批准号:7439039
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2006
-
负责人:CHUN-MING HUANG
-
依托单位:
Immunological Secretomes of the Early Anthrax Infection
-
批准号:7647403
-
项目类别:
-
资助金额:$20.6万
-
财政年份:2006
-
负责人:CHUN-MING HUANG
-
依托单位:
Immunological Secretomes of the Early Anthrax Infection
-
批准号:7891333
-
项目类别:
-
资助金额:$25.5万
-
财政年份:2006
-
负责人:CHUN-MING HUANG
-
依托单位:
Secretomes captured in vivo via ultrafiltration probes
-
批准号:7283959
-
项目类别:
-
资助金额:$16.82万
-
财政年份:2006
-
负责人:CHUN-MING HUANG
-
依托单位:
Secretomes captured in vivo via ultrafiltration probes
-
批准号:7073106
-
项目类别:
-
资助金额:$17.33万
-
财政年份:2006
-
负责人:CHUN-MING HUANG
-
依托单位:
Immunological Secretomes of the Early Anthrax Infection
-
批准号:7263719
-
项目类别:
-
资助金额:$24.26万
-
财政年份:2006
-
负责人:CHUN-MING HUANG
-
依托单位:
Immunological Secretomes of the Early Anthrax Infection
-
批准号:7187396
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2006
-
负责人:CHUN-MING HUANG
-
依托单位:
Secretomes captured in vivo via ultrafiltration probes
-
批准号:7480238
-
项目类别:
-
资助金额:$16.49万
-
财政年份:2006
-
负责人:CHUN-MING HUANG
-
依托单位:
Immunological Secretomes of the Early Anthrax Infection
-
批准号:8068586
-
项目类别:
-
资助金额:$2.51万
-
财政年份:2006
-
负责人:CHUN-MING HUANG
-
依托单位:
Anthrax vaccination by targeting spore germination
-
批准号:7177284
-
项目类别:
-
资助金额:$43.66万
-
财政年份:2004
-
负责人:CHUN-MING HUANG
-
依托单位:
海外基金